Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mapping and role of T cell response in SARS-CoV-2–infected mice
Zhen Zhuang, Xiaomin Lai, Jing Sun, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 4
Open Access | Times Cited: 168

Showing 26-50 of 168 citing articles:

Intranasal administration of a single dose of a candidate live attenuated vaccine derived from an NSP16-deficient SARS-CoV-2 strain confers sterilizing immunity in animals
Zi‐Wei Ye, Chon Phin Ong, Kaiming Tang, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 5, pp. 588-601
Open Access | Times Cited: 34
Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection
Lina Yan, Panpan Liu, Xu-gui Li, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 29
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies
Alexandra J. Spencer, Susan Morris, Marta Ulaszewska, et al.
EBioMedicine (2022) Vol. 77, pp. 103902-103902
Open Access | Times Cited: 27
Exposure to lung-migrating helminth protects against murine SARS-CoV-2 infection through macrophage-dependent T cell activation
Oyebola O. Oyesola, Kerry L. Hilligan, Sivaranjani Namasivayam, et al.
Science Immunology (2023) Vol. 8, Iss. 86
Closed Access | Times Cited: 16
The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality
Yadira Lobaina, Rong Chen, Edith Suzarte, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 418-418
Open Access | Times Cited: 6
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 5
Virus-specific T cell response in SARS-CoV-2 infection and vaccinations
Antonio Bertoletti, Martin Qui, Joey Ming Er Lim
Elsevier eBooks (2025), pp. 191-206
Closed Access
Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infection
Katharina Wørzner, S. Schmidt, Julie Zimmermann, et al.
EBioMedicine (2025) Vol. 113, pp. 105615-105615
Open Access
DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice
Jinni Chen, Yao Deng, Baoying Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Favorable vaccine-induced SARS-CoV-2–specific T cell response profile in patients undergoing immune-modifying therapies
Martin Qui, Nina Le Bert, Webber Chan, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 12
Open Access | Times Cited: 26
Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection
Hye Won Jeong, Se‐Mi Kim, Min Kyung Jung, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100764-100764
Open Access | Times Cited: 26
The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines
Zhongjie Sun, Tingxin Wu, Huangfan Xie, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1103-1103
Open Access | Times Cited: 24
ChAdOx1‐S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination
Maja Cokarić Brdovčak, Jelena Materljan, Marko Šustić, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 6, pp. 936-945
Open Access | Times Cited: 23
Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2
Noam Erez, Hagit Achdout, Yfat Yahalom-Ronen, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 7944-7955
Open Access | Times Cited: 13
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
Patrick O. Azevedo, Natália Satchiko Hojo-Souza, Lídia Faustino, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 12
Microfluidic Synthesis of Scalable Layer-by-Layer Multiple Antigen Nano-Delivery Platform for SARS-CoV-2 Vaccines
Yang Xu, Kazuya Masuda, Christine Groso, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 339-339
Open Access | Times Cited: 4
Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models
Hong‐Yi Zheng, Tian‐Zhang Song, Yong‐Tang Zheng
动物学研究 (2024) Vol. 45, Iss. 4, pp. 747-766
Open Access | Times Cited: 4
Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice
Min‐Wen Ku, Pierre Authié, Maryline Bourgine, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 12
Open Access | Times Cited: 31
The generation of stem cell-like memory cells early after BNT162b2 vaccination is associated with durability of memory CD8+ T cell responses
Sungmin Jung, Jae Hyung Jung, Ji Yun Noh, et al.
Cell Reports (2022) Vol. 40, Iss. 4, pp. 111138-111138
Open Access | Times Cited: 18
Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model
Alexandra Rak, N. Gorbunov, В. А. Костевич, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 230-230
Open Access | Times Cited: 11
Lung T cell response in COVID-19
Mehrnoush Hadaddzadeh Shakiba, Ioanna D. Gemünd, Marc Beyer, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov
Shenyu Wang, Wenqing Liu, Yuqing Li, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 704-713
Open Access | Times Cited: 10
Developing CAR-immune cell therapy against SARS-CoV-2: Current status, challenges and prospects
Yizhao Chen, Chong Liu, Yilong Fang, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116066-116066
Closed Access | Times Cited: 3
The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects
Craig Collins, Dan L. Longo, William J. Murphy
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections
Zhen Zhuang, Jianfen Zhuo, Yaochang Yuan, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 478-478
Open Access | Times Cited: 3

Scroll to top